Inhaled nitric oxide therapy in adults: European expert recommendations.
BACKGROUND
Inhaled nitric oxide (iNO) has been used for treatment of acute respiratory failure and pulmonary hypertension since 1991 in adult patients in the perioperative setting and in critical care.


METHODS
This contribution assesses evidence for the use of iNO in this population as presented to a expert group jointly organised by the European Society of Intensive Care Medicine and the European Association of Cardiothoracic Anaesthesiologists.


CONCLUSIONS
Expert recommendations on the use of iNO in adults were agreed on following presentation of the evidence at the expert meeting held in June 2004.
Department of Anaesthesiology and General Intensive Care, Medical University of Vienna, Waehringerguertel 18-20, 1090 Vienna, Austria. peter.germann@meduniwien.ac.at
Peter
P
Germann
Antonio
A
Braschi
Giorgio
G
Della Rocca
Anh Tuan
AT
Dinh-Xuan
Konrad
K
Falke
Claes
C
Frostell
Lars E
LE
Gustafsson
Philippe
P
Hervé
Philippe
P
Jolliet
Udo
U
Kaisers
Hector
H
Litvan
Duncan J
DJ
Macrae
Marco
M
Maggiorini
Nandor
N
Marczin
Bernd
B
Mueller
Didier
D
Payen
Marco
M
Ranucci
Dietmar
D
Schranz
Rainer
R
Zimmermann
Roman
R
Ullrich
D000280:Administration, Inhalation; D000328:Adult; D005060:Europe; D006333:Heart Failure / Q000628:therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000628:therapy; D009569:Nitric Oxide / Q000008:administration & dosage / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D015427:Reperfusion Injury / Q000628:therapy; D012128:Respiratory Distress Syndrome / Q000628:therapy; D012138:Respiratory Therapy / Q000379:methods
D009569:Nitric Oxide